Introduction
Dear Esteemed Colleagues,
On behalf of the organizing committee, it is our great pleasure to warmly welcome you to the 2025 ECHO360 Structural Heart Imaging Symposium with Asia Valve.
Now entering its 9th year, ECHO360 has become a leading platform for advancing knowledge and fostering collaboration in the field of structural heart imaging. Each year, the symposium has grown in scope and depth, and in 2025 we are excited to continue this tradition by presenting a rich scientific program that bridges innovation with clinical practice.
This year’s symposium will highlight the latest advancements in transcatheter interventions, including TAVI, TEER, TMVR, and emerging therapies for complex valvular heart diseases. In addition, we will dedicate focused sessions to rare cardiac diseases and cardiomyopathies, addressing both diagnostic and therapeutic perspectives. These sessions are designed to enrich our collective understanding and support the development of new strategies for patient care.
The joint program with Asia Valves will once again serve as a forum for meaningful international collaboration, particularly among experts in the Asia-Pacific region. We firmly believe that this exchange of expertise will strengthen global networks and accelerate progress in the management of structural heart diseases.
We are confident that the 2025 ECHO360 will not only provide practical insights and case-based learning, but also inspire new ideas for the future of structural heart imaging. Your participation, experience, and perspectives are invaluable in making this symposium a success, and we look forward to engaging discussions that will shape the next era of cardiac care.
We sincerely invite you to join us for this exciting journey, and we eagerly anticipate welcoming you to Seoul in 2025.
Yours sincerely,
On behalf of the organizing committee, it is our great pleasure to warmly welcome you to the 2025 ECHO360 Structural Heart Imaging Symposium with Asia Valve.
Now entering its 9th year, ECHO360 has become a leading platform for advancing knowledge and fostering collaboration in the field of structural heart imaging. Each year, the symposium has grown in scope and depth, and in 2025 we are excited to continue this tradition by presenting a rich scientific program that bridges innovation with clinical practice.
This year’s symposium will highlight the latest advancements in transcatheter interventions, including TAVI, TEER, TMVR, and emerging therapies for complex valvular heart diseases. In addition, we will dedicate focused sessions to rare cardiac diseases and cardiomyopathies, addressing both diagnostic and therapeutic perspectives. These sessions are designed to enrich our collective understanding and support the development of new strategies for patient care.
The joint program with Asia Valves will once again serve as a forum for meaningful international collaboration, particularly among experts in the Asia-Pacific region. We firmly believe that this exchange of expertise will strengthen global networks and accelerate progress in the management of structural heart diseases.
We are confident that the 2025 ECHO360 will not only provide practical insights and case-based learning, but also inspire new ideas for the future of structural heart imaging. Your participation, experience, and perspectives are invaluable in making this symposium a success, and we look forward to engaging discussions that will shape the next era of cardiac care.
We sincerely invite you to join us for this exciting journey, and we eagerly anticipate welcoming you to Seoul in 2025.
Yours sincerely,
2025 ECHO360 Structural Heart Imaging with Asia Valve
| Program Directors | |
| Geu-Ru Hong (Korea) | |
| Mani A Vannan (USA) | |
| Patrizio Lancellotti (Belgium) |
